Home » Newsletters » BioWorld Science

BioWorld Science

March 30, 2020

View Archived Issues

New mouse model of MLL-ENL-driven AML to understand the early stages of leukemogenesis

Discovery of amide-linked benzimidazole-benzoxaborole hybrids for the treatment of onchocerciasis

Caelum initiates phase II study of CAEL-101 in AL amyloidosis

Phase II results for pembrolizumab in patients with advanced rare cancers

miR15a-1 as a new a noninvasive biomarker for asthma

Sepsis study may yield new treatment strategies

Dead cells do tell tales

TET1 gene therapy patented by the Military Medical Institute Academy

How lung tumors seed to brain

Roche synthesizes new TLR7/TLR8/TLR9 antagonists

Medshine Discovery discovers drugs targeting protein cereblon

New geranylgeranyl transferase type 1 inhibitors identified at Bayer

Abbisko Therapeutics identifies new fibroblast growth factor receptor inhibitors

Investigators describe biomarkers of liver injury

Gimsilumab completes phase I study in development of gimsilumab for COVID-19-related ARDS

NGM studies NGM-395 in obese adults and patients with NAFLD

New Chinese phase I study evaluates Ad5-nCoV coronavirus vaccine

Lundbeck discontinues foliglurax program in Parkinson's following phase IIa results

FDA approves new intravenous formulation of Triferic

Lundbeck reports phase IIa results with Lu-AG06466 in Tourette's syndrome

FDA approves Imfinzi as first-line treatment for extensive-stage SCLC

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...